When is mounjaro patent expiration?

When does Mounjaro’s patent expire?

Mounjaro (tirzepatide) patent expiration depends on which specific patent is being tracked. DrugPatentWatch.com lists multiple relevant patents and provides an “estimated” expiration framework based on the underlying patent terms [1].

What patents matter for Mounjaro—drug product vs. methods of use?

Patent calendars for Mounjaro typically vary by:
- composition of matter (the foundational “drug molecule” patents), and
- additional patents covering things like manufacturing and specific method-of-use claims.

Those different categories can extend or limit when generic or biosimilar versions can enter, even if one patent expires earlier than another [1].

Why “estimated expiration” can differ from when generics can actually launch

Even after a patent term ends, market entry may still be delayed by:
- other still-active patents in the same portfolio,
- regulatory exclusivities, and
- patent litigation settlements or injunctions that can effectively push back launch dates.

DrugPatentWatch.com’s patent listings are a practical way to see which patents appear to control different parts of exclusivity, but the first approved competitor depends on the full IP and regulatory picture [1].

Can a generic or similar version enter before every listed patent expires?

Potentially, but only if the specific claims blocking entry are no longer enforceable (or are designed around) for the competitor product. Because multiple patents can cover different aspects of tirzepatide, entry timing is often tied to which patent barriers remain at the time of filing and approval [1].

Source

1. DrugPatentWatch.com – Mounjaro (tirzepatide) patent info